FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W12443642> ?p ?o ?g. }

• W12443642 abstract "Abstract Deferasirox (DFX) is an iron chelator used to prevent and treat complications related to transfusional iron overload in myelodisplastic syndrome patients (MDS). Intriguingly, DFX treatment induces haematological responses in a consistent percentage of patients whereas other chelators, like deferoxamine (DFO) do not show such an appreciable effect. A body of literature documents a general reduction of oxidative stress in patients treated with DFX but little is known about the direct effect of DFX treatment on hematopoietic stem cells (HSC). Consolidated evidence highlights the importance of redox signalling in the homeostasis of fundamental processes, particularly in controlling the balance between self-renewal and differentiation of stem cells. In this setting, reactive species of oxygen (ROS) would act as secondary messengers, modulating the expression of master transcription factors and regulatory proteins leading or (pre)conditioning stem cells towards differentiation. In the present study we investigated the effect of DFX and DFO on ROS production in hematopoietic stem/progenitor cells (HSPCs) in order to identify a molecular mechanism explaining the differential effect of iron chelators in rescuing altered hematopoiesis. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood of healthy subjects and incubated for 24 hours with DFO and DFX in a range of doses between 6.2mM and 200mM. Human HSPCs, isolated upon informed consent from peripheral blood of G-CSF-treated healthy donors by immuno-selection against the specific markers CD133 and CD34, were treated with 100 mM DFX or DFO for 24 hours. To completely abrogate ROS production, cells were co-incubated with diphenil iodide (DPI) 100mM, a known inhibitor of the main proteins able to generate ROS: the flavo-oxidases of the respiratory chain and the NADPH oxidases. Cell viability was determined by trypan blue staining. ROS levels were analyzed by laser scanning confocal microscopy (LSCM) and flow cytometry after the incubation at 37°C for 15 minutes with the intracellular H2O2 specific probe dichlorodihhyrofluorescein-diacetate (H2DCFDA) 10mM. b-catenin and BMI1 protein levels were assessed by western blotting. Data were presented as mean±s.e.m. and were compared by unpaired Student T-Test; a p<0.05 was considered significant. The flow cytometry analysis on PBMCs revealed that DFX, surprisingly, was able to induce ROS production in a dose-dependent manner with a significant increase at 100mM and 200mM compared to CTRL (p=0.02) whereas DFO treatment didn’t show any effect compared to CTRL. Since the cell viability resulted to be not affected by both drugs, the dose of 100mM was chosen for the following experiments performed with HSPCs where the ability of DFX to cause a significant increase of H2O2 was confirmed. A deeper analysis aimed to clarify the localization of ROS released following DFX treatment was performed by LSCM: a significant up-regulation of mitochondrial ROS induced by DFX and not by DFO was clearly observed compared to untreated samples. Importantly, the addition of DPI strongly reduced the entity of the signal detected by DCF (p=0.01 versus DFX). In order to understand a possible link between ROS production and the ability of DFX to restore the hematopoiesis, the expression of b-catenin and BMI1, both of them sensitive to the intracellular redox state and involved in the hematopoietic function, was analysed by western blotting. It was shown that DFX significantly reduced the expression of both b-catenin, strictly linked to hematopoietic function and BMI1 (p=0.02 versus CTRL), a regulatory protein sustaining immaturity and required for the maintaining of adult self-renewing hematopoietic stem cells. Conversely, no significant variation was observed by DFO treatment. Interestingly, the b-catenin and BMI-1expression downregulations, specifically induced by DFX, were completely reversed by ROS abrogation obtained by DPI treatment. Our results show, for the first time, that DFX treatment, independently on its iron-chelating property, is able to induce ROS production that in turn influences key factors involved in self-renewal/differentiation of hematopoietic stem cells. In this scenario, the modulation of ROS, because of their ability to restore the hematopoietic function, could be taken in account as potential further pharmacological target in MDS treatment. Disclosures: No relevant conflicts of interest to declare." @default.
• W12443642 created "2016-06-24" @default.
• W12443642 creator A5028283823 @default.
• W12443642 creator A5031326564 @default.
• W12443642 creator A5039786016 @default.
• W12443642 creator A5044869604 @default.
• W12443642 creator A5046309539 @default.
• W12443642 creator A5049857312 @default.
• W12443642 creator A5054124337 @default.
• W12443642 creator A5054685615 @default.
• W12443642 creator A5060005797 @default.
• W12443642 creator A5084155072 @default.
• W12443642 date "2013-11-15" @default.
• W12443642 modified "2023-10-15" @default.
• W12443642 title "Effect Of Deferasirox On Reactive Species Of Oxygen (ROS) Production In Hematopoietic Stem Cells: Up Or Down?" @default.
• W12443642 doi "https://doi.org/10.1182/blood.v122.21.1195.1195" @default.
• W12443642 hasPublicationYear "2013" @default.
• W12443642 type Work @default.
• W12443642 sameAs 12443642 @default.
• W12443642 citedByCount "0" @default.
• W12443642 crossrefType "journal-article" @default.
• W12443642 hasAuthorship W12443642A5028283823 @default.
• W12443642 hasAuthorship W12443642A5031326564 @default.
• W12443642 hasAuthorship W12443642A5039786016 @default.
• W12443642 hasAuthorship W12443642A5044869604 @default.
• W12443642 hasAuthorship W12443642A5046309539 @default.
• W12443642 hasAuthorship W12443642A5049857312 @default.
• W12443642 hasAuthorship W12443642A5054124337 @default.
• W12443642 hasAuthorship W12443642A5054685615 @default.
• W12443642 hasAuthorship W12443642A5060005797 @default.
• W12443642 hasAuthorship W12443642A5084155072 @default.
• W12443642 hasConcept C10205521 @default.
• W12443642 hasConcept C109159458 @default.
• W12443642 hasConcept C126322002 @default.
• W12443642 hasConcept C134018914 @default.
• W12443642 hasConcept C185592680 @default.
• W12443642 hasConcept C201750760 @default.
• W12443642 hasConcept C203014093 @default.
• W12443642 hasConcept C2776151105 @default.
• W12443642 hasConcept C2776672577 @default.
• W12443642 hasConcept C2777799968 @default.
• W12443642 hasConcept C2778175917 @default.
• W12443642 hasConcept C2781053155 @default.
• W12443642 hasConcept C28328180 @default.
• W12443642 hasConcept C48349386 @default.
• W12443642 hasConcept C502942594 @default.
• W12443642 hasConcept C55493867 @default.
• W12443642 hasConcept C71924100 @default.
• W12443642 hasConcept C86803240 @default.
• W12443642 hasConcept C95444343 @default.
• W12443642 hasConcept C98274493 @default.
• W12443642 hasConceptScore W12443642C10205521 @default.
• W12443642 hasConceptScore W12443642C109159458 @default.
• W12443642 hasConceptScore W12443642C126322002 @default.
• W12443642 hasConceptScore W12443642C134018914 @default.
• W12443642 hasConceptScore W12443642C185592680 @default.
• W12443642 hasConceptScore W12443642C201750760 @default.
• W12443642 hasConceptScore W12443642C203014093 @default.
• W12443642 hasConceptScore W12443642C2776151105 @default.
• W12443642 hasConceptScore W12443642C2776672577 @default.
• W12443642 hasConceptScore W12443642C2777799968 @default.
• W12443642 hasConceptScore W12443642C2778175917 @default.
• W12443642 hasConceptScore W12443642C2781053155 @default.
• W12443642 hasConceptScore W12443642C28328180 @default.
• W12443642 hasConceptScore W12443642C48349386 @default.
• W12443642 hasConceptScore W12443642C502942594 @default.
• W12443642 hasConceptScore W12443642C55493867 @default.
• W12443642 hasConceptScore W12443642C71924100 @default.
• W12443642 hasConceptScore W12443642C86803240 @default.
• W12443642 hasConceptScore W12443642C95444343 @default.
• W12443642 hasConceptScore W12443642C98274493 @default.
• W12443642 hasLocation W124436421 @default.
• W12443642 hasOpenAccess W12443642 @default.
• W12443642 hasPrimaryLocation W124436421 @default.
• W12443642 hasRelatedWork W1803704300 @default.
• W12443642 hasRelatedWork W1982739579 @default.
• W12443642 hasRelatedWork W2048753210 @default.
• W12443642 hasRelatedWork W2160347187 @default.
• W12443642 hasRelatedWork W2177792457 @default.
• W12443642 hasRelatedWork W2276807168 @default.
• W12443642 hasRelatedWork W2286685462 @default.
• W12443642 hasRelatedWork W2315519380 @default.
• W12443642 hasRelatedWork W2370024235 @default.
• W12443642 hasRelatedWork W2390603214 @default.
• W12443642 hasRelatedWork W2414076414 @default.
• W12443642 hasRelatedWork W2511021477 @default.
• W12443642 hasRelatedWork W2539002223 @default.
• W12443642 hasRelatedWork W2550324066 @default.
• W12443642 hasRelatedWork W2556477738 @default.
• W12443642 hasRelatedWork W2560443961 @default.
• W12443642 hasRelatedWork W2898809558 @default.
• W12443642 hasRelatedWork W2979654877 @default.
• W12443642 hasRelatedWork W2979925563 @default.
• W12443642 hasRelatedWork W3082868970 @default.
• W12443642 isParatext "false" @default.
• W12443642 isRetracted "false" @default.
• W12443642 magId "12443642" @default.
• W12443642 workType "article" @default.